Home Cart 0 Sign in  

[ CAS No. 13033-84-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 13033-84-6
Chemical Structure| 13033-84-6
Structure of 13033-84-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 13033-84-6 ]

Related Doc. of [ 13033-84-6 ]

Alternatived Products of [ 13033-84-6 ]

Product Details of [ 13033-84-6 ]

CAS No. :13033-84-6 MDL No. :MFCD00066112
Formula : C10H14ClNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :SWVMLNPDTIFDDY-SBSPUUFOSA-N
M.W : 215.68 Pubchem ID :11481330
Synonyms :
Methyl (R)-phenylalaninate hydrochloride;Methyl D-phenylalaninate hydrochloride;D-Phe-OMe monohydrochloride
Chemical Name :(R)-Methyl 2-amino-3-phenylpropanoate hydrochloride

Calculated chemistry of [ 13033-84-6 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 56.79
TPSA : 52.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.59 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 1.45
Log Po/w (WLOGP) : 1.53
Log Po/w (MLOGP) : 1.7
Log Po/w (SILICOS-IT) : 1.37
Consensus Log Po/w : 1.21

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.14
Solubility : 1.55 mg/ml ; 0.00718 mol/l
Class : Soluble
Log S (Ali) : -2.15
Solubility : 1.51 mg/ml ; 0.00701 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.57
Solubility : 0.586 mg/ml ; 0.00272 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.75

Safety of [ 13033-84-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 13033-84-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 13033-84-6 ]
  • Downstream synthetic route of [ 13033-84-6 ]

[ 13033-84-6 ] Synthesis Path-Upstream   1~25

  • 1
  • [ 673-06-3 ]
  • [ 13033-84-6 ]
YieldReaction ConditionsOperation in experiment
100% at 70℃; Cooling EXAMPLE 4: SYNTHESIS OF D-PHENYLALANINE METHYLESTER APPENDED NAPHTHALENEDIIMIDE (D-NDI or NDI 3B): SYNTHESIS OF D-PHENYLALANINE METHYLESTER HYDROCHLORIDE:Anhydrous methanol (50 mL) is taken in a 100 mL 2-necked round bottom flask fitted with a reflux condenser and an additional dropping funnel and cooled to ice temperature. Acetyl chloride (3 mL) is added drop wise through the dropping funnel. After 15 min, D-phenylalanine (3 g, 18.16 mmol) is added and the reaction mixture is refluxed at 70 °C for overnight. The reaction mixture is vacuo dried to obtain D- phenylalanine methylester hydrochloride in quantitative yield and used for further reaction without purification. 1,4,5,8-naphthalenetetracarboxylic dianhydride (200 mg, 0.74 mmol) and D- phenylalanine methylester hydrochloride (322 mg 1.49 mmol) is suspended in DMF (20 mL) in a 100 mL round bottom flask. To this suspension triethylamine (0.6 mL) is added under inert atmosphere. The reaction mixture is refluxed at 75 °C for 24 h. Solvent is evaporated under vacuo and the residue is purified by column chromatography (1 percent methanol in chloroform). Yield 71percent. .H NMR (400 MHz, CDC13): δ 8.63 (s, 4H), 7.1 (m, 10H), 6.02 (dd, 2H, J = 4Hz, 4Hz), 3.77 (s, 6H), 3.73 (dd, 2H, J = 8Hz, 4Hz), 3.50 (dd, 2H, J= 12 Hz, 4 Hz). 13C NMR (400 MHz, CDCI3) δ 169.6, 162.4, 136.9, 131.3, 129.2, 128.5, 126.9, 126.8, 126.4, 54.9, 52.8, 34.9. MS (EI): m/z = 590.17 [M]+ for C34H26N2O8. Elemental analysis: Found: C, 69.10; H, 4.49; N, 4.78; Calcd: C, 69.15; H, 4.44; N, 4.74 for C34H26N2O8.
97% With thionyl chloride In methanol 107a.
(D)-Phenylalanine methyl ester hydrochloride
(D)-Phenylalanine (25.0 g) was dissolved in 450 mL of methanol and 22 mL thionyl chloride were slowly added at -20° C.
The mixture was refluxed for 1 h, followed by evaporation of the volatiles to give 31.2 g (97percent) of the title compound as a white solid. M.p. 155-163° C.
Reference: [1] Patent: WO2012/98439, 2012, A1, . Location in patent: Page/Page column 17
[2] Patent: US6194409, 2001, B1,
  • 2
  • [ 67-56-1 ]
  • [ 28069-46-7 ]
  • [ 13033-84-6 ]
YieldReaction ConditionsOperation in experiment
90% at -10 - 20℃; for 16 h; General procedure: For the synthesis of compounds 2a, 2c–2g, we used slightly modificated known procedure [1]. To a stirred solution of amino acid (32.2mmol) in dry methanol (100mL) was added drop-wise thionyl chloride (64.4mmol). The temperature was kept between−10 and−5°C. After complete addition, the reaction was stirred at RT overnight. After 16h, the solution was evaporated to dryness. The product was diluted with EtOAc and collected by filtration. The residue was dried under reduced pressure to give an amino acid methyl ester hydrochloride as white crystalline powder. The yields were higher in all experiments than 80percent. Melting point and 1H as well as 13C NMR spectra in D2O were used for characterization of the prepared compounds. The data are in good agreement with literature data [20].
Reference: [1] European Journal of Medicinal Chemistry, 2013, vol. 68, p. 253 - 259
[2] European Journal of Medicinal Chemistry, 2009, vol. 44, # 1, p. 131 - 142
  • 3
  • [ 67-56-1 ]
  • [ 673-06-3 ]
  • [ 13033-84-6 ]
YieldReaction ConditionsOperation in experiment
100% at 0 - 75℃; for 2 h; General procedure: The methyl-esterification reaction of L-phenylalanine.To a suspension of L-phenylalanine (1 g, 6.05 mmol, 1.0 equiv) inmethanol (25 mL) cooled to 0 C was added thionyl chloride(475 mL, 6.66 mmol, 1.5 equiv) slowly. After 10 min, the reactionmixture was heated to 75 C to reflux for 2 h. After completion(monitored by TLC), the solvent was removed in vacuo, and at thistime, a white solid was formed methyl L-phenylalaninate hydrochloride(1.23 g, quantitative yield).
100% at 0 - 20℃; for 1 h; D-Phenylalanine (1.3 g, 7.8 mmol) wasdissolved in dry MeOH and cooled to 0°C in an ice bath. Thionyl chloride (2.85 mL, 39.3 mmol) wasadded dropwise. The reaction mixture warmed to room temperature and stirred for 1 h. The solvent andreagent were removed under reduced pressure to yield the hydrochloride salt 8 as a white solid inquantitative yield. LRMS (ESI) m/z =180.3 [M+H]+.
94.1% at 0 - 40℃; for 8 h; 66.0 g (0.40 mol) of D-phenylalanine were suspended at room temperature in 400 ml of methanol in an anhydrous flask.
The thus obtained white suspension was cooled to a temperature of 0+-5° C., and then 56.0 ml of tionyl chloride were added drop wise in about 2 hours, maintaining the temperature in the range 0+-5° C.
The temperature of the suspension thus obtained was brought up to 40+-5° C., and maintained for 6 hours, then returned to room temperature.
The reaction mixture was stirred overnight at room temperature, and then concentrated under vacuum so as to remove most of the solvent; the residue was dissolved in 200 ml of toluene, and the thus obtained solution was concentrated under vacuum once more, until a residue able to be stirred was obtained.
To this residue 400 ml of acetone were added, and the thus obtained suspension was cooled to a temperature of 0+-5° C. for 2 hours.
A solid product was formed, which is filtered and washed with acetone (2*50 ml), thus obtaining 83.34 g of wet white product, corresponding to 81.09 g of dry D-phenylalanine methyl ester hydrochloride (yield=94.1percent).
94.1% at 0 - 45℃; EXAMPLE 1
Preparation of D-phenylalanine methyl ester hydrochloride.
66.0 g (0.40 mol) of D-phenylalanine were suspended at room temperature in 400 ml of methanol in an anhydrous flask.
The thus obtained white suspension was cooled to a temperature of 0+-5°C, and then 56.0 ml of tionyl chloride were added drop wise in about 2 hours, maintaining the temperature in the range 0+-5°C.
The temperature of the suspension thus obtained was brought up to 40+-5°C, and maintained for 6 hours, then returned to room temperature.
The reaction mixture was stirred overnight at room temperature, and then concentrated under vacuum so as to remove most of the solvent; the residue was dissolved in 200 ml of toluene, and the thus obtained solution was concentrated under vacuum once more, until a residue able to be stirred was obtained.
To this residue 400 ml of acetone were added, and the thus obtained suspension was cooled to a temperature of 0+-5°C for 2 hours.
A solid product was formed, which is filtered and washed with acetone (2 x 50 ml), thus obtaining 83.34 g of wet white product, corresponding to 81.09 g of dry D-phenylalanine methyl ester hydrochloride (yield = 94.1percent).
93.85% at 0 - 40℃; for 22 h; Example 1: Preparation of D-Phenylalanine methyl ester hydrochloride; Methanol (1200 mL) and D-phenylalanine (200 g) were taken in a round bottom flask at 25-30 0C and cooled to 0 +/- 5 0C. Thionyl chloride (172.8 mL) was added to the above reaction mixture over 2 hours and the temperature was raised to 25-3O0C. The contents were maintained for 12 hours at 40 +/- 5°C. The contents were cooled to 25-3O0C and maintained for 8 hours. Methanol was completely distilled out under vacuum condition at below 450C. To the above crude, 1200 mL of acetone was added and the mixture was cooled slowly to 0-50C in 2 hours. The compound was filtered and washed with 100 mL of acetone. The material was dried for 8 hours at 45-500C under vacuum to obtain the title compound (244g, 93.85percent ), HPLC purity : 99.80percent.
84% at 0 - 22℃; for 26 h; General procedure: To a suspension of 5 g of D-amino acid in 100 mLdry methanol at 0–5°, 8–10 mL thionyl chloridewere added dropwise, the mixture was stirred for 2 hand kept at 20–22° for 24 h. The solvent was evaporatedunder vacuum at 30–40°, the residue wasmixed with dry ether, filtered off, dried, and recrystallizedfrom methanol–ether mixture.

Reference: [1] Bulletin of the Chemical Society of Japan, 1992, vol. 65, # 2, p. 360 - 365
[2] Journal of Natural Products, 2009, vol. 72, # 1, p. 172 - 176
[3] European Journal of Medicinal Chemistry, 2018, vol. 145, p. 649 - 660
[4] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 4, p. 637 - 641
[5] European Journal of Organic Chemistry, 2010, # 22, p. 4276 - 4287
[6] Chemistry - A European Journal, 2013, vol. 19, # 49, p. 16615 - 16624
[7] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 17, p. 4778 - 4799
[8] Helvetica Chimica Acta, 2000, vol. 83, # 2, p. 394 - 406
[9] Bulletin de la Societe Chimique de France, 1995, vol. 132, # 7, p. 709 - 720
[10] Patent: US2006/148902, 2006, A1, . Location in patent: Page/Page column 4
[11] Patent: EP1535900, 2005, A1, . Location in patent: Page/Page column 6
[12] Patent: WO2010/106550, 2010, A2, . Location in patent: Page/Page column 17
[13] Journal of Organic Chemistry, 2004, vol. 69, # 9, p. 3240 - 3241
[14] Chemical and Pharmaceutical Bulletin, 2006, vol. 54, # 8, p. 1170 - 1174
[15] Russian Journal of Bioorganic Chemistry, 2017, vol. 43, # 4, p. 456 - 462[16] Bioorg. Khim., 2017, vol. 43, # 4, p. 427 - 434,8
[17] Chemistry - A European Journal, 2016, vol. 22, # 9, p. 3148 - 3155
[18] European Journal of Medicinal Chemistry, 1986, vol. 21, # 4, p. 333 - 338
[19] Journal of Organic Chemistry, 1986, vol. 51, # 14, p. 2728 - 2735
[20] Agricultural and Biological Chemistry, 1987, vol. 51, # 2, p. 537 - 548
[21] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 4, p. 637 - 640
[22] Journal of Medicinal Chemistry, 2006, vol. 49, # 24, p. 7215 - 7226
[23] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 7, p. 1897 - 1902
[24] European Journal of Medicinal Chemistry, 2009, vol. 44, # 10, p. 3922 - 3929
[25] Patent: WO2005/121071, 2005, A1, . Location in patent: Page/Page column 14-16
[26] Patent: WO2011/157986, 2011, A1, . Location in patent: Page/Page column 17-18
[27] Chemistry - A European Journal, 2012, vol. 18, # 16, p. 4818 - 4822
[28] Green Chemistry, 2012, vol. 14, # 5, p. 1350 - 1356
[29] Advanced Synthesis and Catalysis, 2012, vol. 354, # 17, p. 3327 - 3332
[30] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 7, p. 764 - 769
[31] Journal of Polymer Science, Part A: Polymer Chemistry, 2016, vol. 54, # 8, p. 1065 - 1077
[32] Tetrahedron, 2016, vol. 72, # 51, p. 8486 - 8492
[33] Chemical Communications, 2017, vol. 53, # 2, p. 447 - 450
  • 4
  • [ 673-06-3 ]
  • [ 77-76-9 ]
  • [ 13033-84-6 ]
Reference: [1] Journal of Medicinal Chemistry, 1980, vol. 23, # 11, p. 1232 - 1235
[2] Journal of the American Chemical Society, 1981, vol. 103, # 14, p. 4231 - 4239
[3] Tetrahedron Asymmetry, 2008, vol. 19, # 1, p. 67 - 81
  • 5
  • [ 673-06-3 ]
  • [ 75-36-5 ]
  • [ 13033-84-6 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 11, p. 2560 - 2563
[2] European Journal of Organic Chemistry, 2013, # 26, p. 5838 - 5847
  • 6
  • [ 67-56-1 ]
  • [ 18942-49-9 ]
  • [ 13033-84-6 ]
Reference: [1] Journal of Organic Chemistry, 1999, vol. 64, # 25, p. 9294 - 9296
  • 7
  • [ 5619-07-8 ]
  • [ 7524-50-7 ]
  • [ 13033-84-6 ]
Reference: [1] Patent: WO2010/148191, 2010, A2, . Location in patent: Page/Page column 45-49; 59
  • 8
  • [ 37440-07-6 ]
  • [ 13033-84-6 ]
Reference: [1] Tetrahedron Asymmetry, 1993, vol. 4, # 9, p. 2047 - 2051
  • 9
  • [ 5619-07-8 ]
  • [ 13033-84-6 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1992, vol. 65, # 7, p. 1751 - 1754
[2] Advanced Synthesis and Catalysis, 2012, vol. 354, # 17, p. 3327 - 3332
  • 10
  • [ 55322-26-4 ]
  • [ 13033-84-6 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 11, p. 1215 - 1218
  • 11
  • [ 13673-95-5 ]
  • [ 13033-84-6 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 11, p. 1215 - 1218
  • 12
  • [ 19901-50-9 ]
  • [ 13033-84-6 ]
Reference: [1] Tetrahedron Asymmetry, 1993, vol. 4, # 9, p. 2047 - 2051
  • 13
  • [ 63658-18-4 ]
  • [ 13033-84-6 ]
Reference: [1] Tetrahedron Asymmetry, 1993, vol. 4, # 9, p. 2047 - 2051
  • 14
  • [ 108321-83-1 ]
  • [ 13033-84-6 ]
Reference: [1] Advanced Synthesis and Catalysis, 2012, vol. 354, # 17, p. 3327 - 3332
  • 15
  • [ 150-30-1 ]
  • [ 13033-84-6 ]
Reference: [1] Advanced Synthesis and Catalysis, 2012, vol. 354, # 17, p. 3327 - 3332
  • 16
  • [ 7647-01-0 ]
  • [ 673-06-3 ]
  • [ 13033-84-6 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 1806,1809
  • 17
  • [ 67-56-1 ]
  • [ 63-91-2 ]
  • [ 13033-84-6 ]
Reference: [1] Asian Journal of Chemistry, 2012, vol. 24, # 3, p. 1170 - 1174
  • 18
  • [ 1202242-82-7 ]
  • [ 1202242-75-8 ]
  • [ 13033-84-6 ]
Reference: [1] Tetrahedron Asymmetry, 2009, vol. 20, # 19, p. 2293 - 2298
  • 19
  • [ 1202242-86-1 ]
  • [ 1202242-76-9 ]
  • [ 13033-84-6 ]
Reference: [1] Tetrahedron Asymmetry, 2009, vol. 20, # 19, p. 2293 - 2298
  • 20
  • [ 1202242-90-7 ]
  • [ 1202242-77-0 ]
  • [ 13033-84-6 ]
Reference: [1] Tetrahedron Asymmetry, 2009, vol. 20, # 19, p. 2293 - 2298
  • 21
  • [ 1202242-95-2 ]
  • [ 1202242-78-1 ]
  • [ 13033-84-6 ]
Reference: [1] Tetrahedron Asymmetry, 2009, vol. 20, # 19, p. 2293 - 2298
  • 22
  • [ 13033-84-6 ]
  • [ 132278-63-8 ]
Reference: [1] Journal of the American Chemical Society, 2000, vol. 122, # 17, p. 4243 - 4244
  • 23
  • [ 13033-84-6 ]
  • [ 77119-85-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 2, p. 211 - 220
  • 24
  • [ 13033-84-6 ]
  • [ 144836-90-8 ]
Reference: [1] Bulletin of the Polish Academy of Sciences, Chemistry, 1989, vol. 37, # 9-12, p. 363 - 370
  • 25
  • [ 13033-84-6 ]
  • [ 105816-04-4 ]
Reference: [1] Patent: WO2011/157986, 2011, A1,
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 13033-84-6 ]

Nateglinide Intermediates

Chemical Structure| 536-66-3

[ 536-66-3 ]

4-Isopropylbenzoic acid

Similar Product of
[ 13033-84-6 ]

Chemical Structure| 21685-51-8

A500087[ 21685-51-8 ]

(R)-Methyl 2-amino-3-phenylpropanoate

Reason: Free-salt

Related Functional Groups of
[ 13033-84-6 ]

Amino Acid Derivatives

Chemical Structure| 2577-90-4

[ 2577-90-4 ]

(S)-Methyl 2-amino-3-phenylpropanoate

Similarity: 0.98

Chemical Structure| 3182-93-2

[ 3182-93-2 ]

Ethyl L-phenylalaninate hydrochloride

Similarity: 0.96

Chemical Structure| 19881-53-9

[ 19881-53-9 ]

H-DL-Phe-OEt.HCl

Similarity: 0.96

Chemical Structure| 90940-54-8

[ 90940-54-8 ]

D-Homophenylalanine ethyl ester hydrochloride

Similarity: 0.94

Chemical Structure| 90891-21-7

[ 90891-21-7 ]

H-HoPhe-OEt.HCl

Similarity: 0.94